Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Cantor Fitzgerald Maintains Neutral on Momenta Pharmaceuticals, Raises Price Target to $52.5


Benzinga | Aug 20, 2020 07:51AM EDT

Cantor Fitzgerald Maintains Neutral on Momenta Pharmaceuticals, Raises Price Target to $52.5

Cantor Fitzgerald maintains Momenta Pharmaceuticals (NASDAQ:MNTA) with a Neutral and raises the price target from $38 to $52.5.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC